Novel class of pain drugs based on antagonism of NGF

被引:295
作者
Hefti, FF
Rosenthal, A
Walicke, PA
Wyatt, S
Vergara, G
Shelton, DL
Davies, AM
机构
[1] Univ Cardiff, Cardiff Sch Biosci, Cardiff CF10 3US, Wales
[2] Rinat Neurosci Corp, San Francisco, CA 94080 USA
基金
英国惠康基金;
关键词
D O I
10.1016/j.tips.2005.12.001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nerve growth factor (NGF) was identified originally as a survival factor for sensory and sympathetic neurons in the developing nervous system. In adults, NGF is not required for survival but it has a crucial role in the generation of pain and hyperalgesia in several acute and chronic pain states. The expression of NGF is high in injured and inflamed tissues, and activation of the NGF receptor tyrosine kinase trkA on nociceptive neurons triggers and potentiates pain signalling by multiple mechanisms. Inhibition of NGF function and signalling blocks pain sensation as effectively as cyclooxygenase inhibitors and opiates in rodent models of pain. Several pharmaceutical companies have active drug-discovery and development programs that are based on a variety of approaches to antagonise NGF, including NGF 'capture', blocking the binding of NGF to trkA and inhibiting trkA signalling. NGF antagonism is expected to be a highly effective therapeutic approach in many pain states, and to be free of the adverse effects of traditional analgesic drugs.
引用
收藏
页码:85 / 91
页数:7
相关论文
共 69 条
[1]   NERVE GROWTH-FACTOR IN THE SYNOVIAL-FLUID OF PATIENTS WITH CHRONIC ARTHRITIS [J].
ALOE, L ;
TUVERI, MA ;
CARCASSI, U ;
LEVIMONTALCINI, R .
ARTHRITIS AND RHEUMATISM, 1992, 35 (03) :351-355
[2]  
Apfel SC, 2002, INT REV NEUROBIOL, V50, P393
[3]   Nerve growth factor regulates the expression of brain-derived neurotrophic factor mRNA in the peripheral nervous system [J].
Apfel, SC ;
Wright, DE ;
Wiideman, AM ;
Dormia, C ;
Snider, WD ;
Kessler, JA .
MOLECULAR AND CELLULAR NEUROSCIENCE, 1996, 7 (02) :134-142
[4]   p75NTR is positively promiscuous: Novel partners and new insights [J].
Barker, PA .
NEURON, 2004, 42 (04) :529-533
[5]  
BENNETT DLH, 1999, PAIN NEUROGENIC INFL, P167
[6]   Nerve growth factor evokes hyperalgesia in mice lacking the low-affinity neurotrophin receptor p75 [J].
Bergmann, I ;
Reiter, R ;
Toyka, KV ;
Koltzenburg, M .
NEUROSCIENCE LETTERS, 1998, 255 (02) :87-90
[7]   Signalling pathways involved in the sensitisation of mouse nociceptive neurones by nerve growth factor [J].
Bonnington, JK ;
McNaughton, PA .
JOURNAL OF PHYSIOLOGY-LONDON, 2003, 551 (02) :433-446
[8]   Specific involvement of PKC-ε in sensitization of the neuronal response to painful heat [J].
Cesare, P ;
Dekker, LV ;
Sardini, A ;
Parker, PJ ;
McNaughton, PA .
NEURON, 1999, 23 (03) :617-624
[9]   Differential activity of the nerve growth factor (NGF) antagonist PD90780 [7-(benzolylamino)-4,9-dihydro-4-methyl-9-oxo-pyrazolo[5,1-b]quinazoline-2-carboxylic acid] suggests altered NGF-p75NTR interactions in the presence of TrkA [J].
Colquhoun, A ;
Lawrance, GM ;
Shamovsky, IL ;
Riopelle, RJ ;
Ross, GM .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 310 (02) :505-511
[10]   New embo member's review - Regulation of neuronal survival and death by extracellular signals during development [J].
Davies, AM .
EMBO JOURNAL, 2003, 22 (11) :2537-2545